References
- 1. Mackness B, Durrington PN, Mackness MI. The paraoxonase gene family and coronary heart disease. Curr Opinion Lipidol 2002; 13: 357-62.
- 2. Draganov, D. I., and B. N. La DuPharmacogenetics of paraoxonases: a brief review. Naunyn Schmiedebergs Arch Pharmacol 2004; 369: 78-88.
- 3. Furlong CE, Richter RJ, Li WF, Brophy VH, Carlson C, Rieder M, Nickerson D, Costa LG, Ranchalis J, Lusis AJ, Shih DM, Tward A, Jarvik GP., The functional consequences of polymorphisms in the PON1 gene. In: The Paraoxonase: Their Role in Disease Development and Xenobiotic Metabolism. Mackness B, Mackness M, Aviram M and Paragh G. (eds.) Springer, Dordrecht, Netherlands: 2008; Chapter 17, 267-281
- 4. Roest, M., T. M. van Himbergen, A. B. Barendrecht, P. H. Peeters, Y. T. van der Schouw, and H. A. Voorbij.. Genetic and environmental determinants of the PON-1 phenotype. Eur J Clin Invest 2007; 37: 187-196.
- 5. Mackness M, Mackness B. Paraoxonase 1 and atherosclerosis: Is the gene or the protein more important? Free Radic Bio Med 2004; 37(9): 1317-23
- 6. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983; 51(3): 606.
- 7. Eckerson HW, Wyte CM, La Du BN. The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 1983; 35(6): 1126-1138.
- 8. R Development Core Team. (2012). R (Version 2.15). Retrieved from www.r-project.org
- 9. Brophy VH, Jampsa RL, Clendenning JB, McKinstry LA, Jarvik JP, Furlong CE. Effets of 5’ regulatory region polymorphisms on paraoxonase-gene (PON1) expression. Am J Hum Genet 2001; 68: 1428-1436.
- 10. Leviev I, James RW. Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations. Arterioscler Thromb Vasc Biol 2001; 20: 516-521.
- 11. Mackness B, Turkie W, Mackness M. Paraoxonase 1 (PON1) promoter region polymorphisms, serum PON1 status and coronary heart disease. Arch Med Sci 2013; 9(1): 8-13.
- 12. Furlong CE. Paraoxonase: an historical perspective. In: The Paraoxonase: Their Role in Disease Development and Xenobiotic Metabolism. Mackness B, Mackness M, Aviram M and Paragh G. (eds.) Springer, Dordrecht, Netherlands: 2008; 3-31.
- 13. Wheeler JG, Keavney BD, Watkins H, Collins R, Danesh J. Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studies. Lancet 2004; 363: 689-695.